National Health Investors, a US medical real estate investment trust, recently filed documents with the US Securities and Exchange Commission disclosing that the preliminary transaction price for one of its property acquisitions is $560 million.

According to the terms of the document, the amount will fluctuate accordingly based on subsequent adjustment mechanisms. This filing submitted to regulators shows that the parties to the transaction set a price adjustment clause in the agreement, meaning that the final transaction price may be higher or lower than the currently announced benchmark price. Such clauses are common in large real estate transactions and are typically used to address possible changes in asset status before deal completion. As a listed company focused on healthcare real estate investment, National Health Investors' latest acquisition initiative is in line with its strategy of continually expanding its healthcare real estate portfolio. The specific triggering conditions and calculation methods for the price adjustment mechanism were not detailed in the disclosure document.